⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methoxymethane SCHEMBL29037433 | 0.94 | KDM4E (0.54) | — | |
| SCHEMBL14590766 | 0.93 | HIF1A (0.65) | — | |
| SCHEMBL9636118 | 0.91 | KDM4E (0.70) | — | |
| SCHEMBL29951519 | 0.91 | KDM4E (0.70) | — | |
| SCHEMBL19816502 | 0.91 | KDM4E (0.70) | — | |
| SCHEMBL204637 | 0.91 | KDM4E (0.70) | — | |
| SCHEMBL15743759 | 0.91 | KDM4E (0.70) | — | |
| SCHEMBL8810970 | 0.91 | KDM4E (0.70) | — | |
| SCHEMBL19606333 | 0.91 | KDM4E (0.70) | — | |
| SCHEMBL293767 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113194969-A | Compositions for treating skin conditions | 弗特附属公司 | 2021-07-30 | — | — | CN | claimed |
| US-20210186998-A1 | COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS | FORTE SUBSIDIARY, INC. | 2021-06-24 | — | — | US | claimed |
| EP-3790563-A1 | COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS | Forte Subsidiary, Inc. (US) | 2021-03-17 | — | — | EP | claimed |
| WO-2019217203-A1 | COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS | FORTE BIOSCIENCES, INC (US) | 2019-11-14 | — | — | WO | claimed |
| US-20190343856-A1 | COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS | FORTE SUBSIDIARY, INC. | 2019-11-14 | — | — | US | claimed |
| CN-105132486-A | PROCESS FOR THE PREPARATION OF 1,4-BUTANEDIAMINE VIA N-ACYL OR N-GUANIDYL PROTECTED 1,4-BUTANEDIAMINE PRECURSORS | DSM IP ASSETS BV | 2015-12-09 | — | — | CN | claimed |
| CN-102471789-B | Process for the preparation of 1, 4-butanediamine via N-acyl or N-guanidino protected 1, 4-butanediamine precursors | DSM IP ASSETS B.V. (NL) | 2015-08-19 | — | — | CN | claimed |
| US-8999680-B2 | Preparation of 1,4-diaminobutane | DSM IP ASSETS B.V. (NL) | 2015-04-07 | — | — | US | claimed |
| US-20120190087-A1 | PREPARATION OF 1,4-DIAMINOBUTANE | ENVALIOR B.V. (NL) | 2012-07-26 | — | — | US | claimed |
| EP-2456879-A1 | PROCESS FOR THE PREPARATION OF 1,4-BUTANEDIAMINE VIA N-ACYL OR N-GUANIDYL PROTECTED 1,4-BUTANEDIAMINE PRECURSORS | DSM IP Assets B.V. (NL) | 2012-05-30 | — | — | EP | claimed |
| CN-102471789-A | Process for the preparation of 1, 4-butanediamine via N-acyl or N-guanidino protected 1, 4-butanediamine precursors | DSM IP ASSETS BV | 2012-05-23 | — | — | CN | claimed |
| WO-2011009859-A1 | PROCESS FOR THE PREPARATION OF 1,4-BUTANEDIAMINE VIA N-ACYL OR N-GUANIDYL PROTECTED 1,4-BUTANEDIAMINE PRECURSORS | DSM IP ASSETS B.V. (NL) | 2011-01-27 | — | — | WO | claimed |
| US-20100190688-A1 | Tetrapeptide analogs | IDUN PHARMACEUTICALS, INC. | 2010-07-29 | — | — | US | claimed |
| EP-1773348-A4 | TETRAPEPTIDE ANALOGS | IDUN PHARMACEUTICALS INC (US) | 2009-05-20 | — | — | EP | claimed |
| CN-101094833-A | Tetrapeptide analogs | IDUN PHARMACEUTICALS INC (US) | 2007-12-26 | — | — | CN | claimed |
| EP-1773348-A2 | TETRAPEPTIDE ANALOGS | Idun Pharmaceuticals, Inc. (US) | 2007-04-18 | — | — | EP | claimed |
| WO-2006017295-A2 | TETRAPEPTIDE ANALOGS | IDUN PHARMACEUTICALS, INC. (US) | 2006-02-16 | — | — | WO | claimed |
| EP-4181781-B1 | BREATH-BASED THERAPEUTIC DRUG MONITORING METHOD | UNIV KINDERSPITAL BEIDER BASEL (CH) | 2026-05-20 | — | — | EP | disclosed |
| US-4000261-A | 5-EPI-4,6-DI-O-(AMINOGLYCOSYL)-2-DEOXYSTREPTAMINES, METHODS FOR THEIR MANUFACTURE AND INTERMEDIATES USEFUL THEREIN, METHODS FOR THEIR USE AS ANTIBACTERIAL AGENTS AND COMPOSITIONS USEFUL THEREFOR | SCHERING CORPORATION (US) | 1976-12-28 | — | — | US | disclosed |
| US-4000262-A | 5-EPI-AMINO AND 5-EPI-AZIDO-4,6-DI-O-(AMINOGLYCOSYL)-2,5-DIDEOXYSTREPTAMINES 1-N-ALKYL-5-EPI-AMINO AND 1-N-ALKYL-5-EPI-AZIDO-4,6-DI-O-(AMINOGLYCOSYL)-2,5-DIDEOXYSTREPTAMINES | SCHERING CORPORATION (US) | 1976-12-28 | — | — | US | disclosed |